- Joint investment to capture sizeable market opportunities and significantly increase Abu Dhabi’s capacity to deliver comprehensive veterinary healthcare and vaccinations
- State-of-the-art equine and camel hospitals will be developed in Abu Dhabi
- A new facility for advanced animal vaccine treatments is planned to serve the Middle East and Africa
ADQ, an Abu Dhabi-based investment and holding company, and E20 Investment, an agribusiness investment company in the UAE, today entered into an agreement to establish a new animal health platform in Abu Dhabi, representing a landmark milestone for the region’s animal healthcare industry.
The animal health platform will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals. Once operational, the facilities will further enhance Abu Dhabi’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.
Established in 2018, ADQ is an Abu Dhabi-based investment and holding company with a broad portfolio of major enterprises. Its investments span key sectors of the UAE’s diversified economy including energy and utilities, food and agriculture, healthcare and life sciences, and mobility and logistics, amongst others. As a strategic partner of Abu Dhabi’s government, ADQ is committed to accelerating the transformation of the Emirate into a globally competitive and knowledge-based economy.
For more information, visit adq.ae or write to firstname.lastname@example.org. You can also follow ADQ on Twitter, Instagram and LinkedIn.
Direct to your inbox
ADQ News and Insights delivered directly to your inbox